{"id": 692, "input_str": " OTTAWA, ONTARIO --(Marketwired - Nov. 16, 2017 ) - Tetra Bio-Pharma Inc. (\"Tetra\" or the \"Company\") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global", "correct_token_str": " leader", "generated_token_str": " student", "generator_index": 0, "correct_logprobs": [-7.145603656768799, -0.8836190104484558, -1.1769413948059082], "generated_logprobs": [-6.578879356384277, -11.068159103393555, -10.919921875], "generator_names": ["gelu_two_layers/", "gelu_twelve_layers/", "gelu_twenty_four_layers/"]}